Current pharmacological treatments for Parkinson's dis- ease are not entirely adequate. A high proportion of patients chronically treated with levodopa and other dopaminergic drugs develop motor complications (fluctua- tions and dyskinesiae) and psychiatric complications.1 2 Additionally, some specific motor functions such as gait, balance, speech, deglutition, etc, become less responsive as disease and duration of treatment increase. It seems that both "non-physiological" dopaminergic stimulation
No takes yet. Share an insight, caveat, or question.
Obeso et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: